BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37620978)

  • 21. Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma.
    Di Cataldo A; Dau D; Conte M; Parodi S; De Bernardi B; Giuliano M; Pession A; Viscardi E; Luksch R; Castellano A; Bertuna G; Haupt R;
    Med Sci Monit; 2009 Jan; 15(1):MT11-8. PubMed ID: 19114976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
    Sies CW; Florkowski CM; Sullivan M; Mackay R; George PM
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):300-5. PubMed ID: 16824281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum neuron-specific/nonneuronal enolase ratio in the diagnosis of neuroblastomas.
    Viallard JL; Tiget F; Hartmann O; Lemerle J; Demeocq F; Malpuech G; Dastugue B
    Cancer; 1988 Dec; 62(12):2546-53. PubMed ID: 3191453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new urinary mass screening system for neuroblastoma in infancy by use of monoclonal antibodies against VMA and HVA.
    Yokomori K; Hori T; Tsuchida Y; Kuroda M; Yoshioka M
    J Pediatr Surg; 1989 Apr; 24(4):391-4. PubMed ID: 2659761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma].
    Hervás Benito I; Rivas Sánchez A; Bello Arques P; Cañete A; Fernández JM; Saura Quiles A; González Cabezas P; Ruiz Rodríguez JC; Castell V; Pérez Pastor JL; Monfort JA; Mateo Navarro A
    Rev Esp Med Nucl; 2001 Aug; 20(5):369-76. PubMed ID: 11470071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
    Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
    Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of an LC-MS/MS Method for the Simultaneous Quantification of Homovanillic Acid and Vanillylmandelic Acid for the Diagnosis and Follow-Up of Neuroblastoma in 357 Patients.
    Hwang N; Chong E; Oh H; Cho HW; Lee JW; Sung KW; Lee SY
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34200415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of CT and MRI combined with serum LDH, NSE, CEA, and MYCN in pediatric neuroblastoma.
    Hao J; Sang J; Xu X; Bao A
    World J Surg Oncol; 2023 Aug; 21(1):251. PubMed ID: 37592273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
    Tuchman M; Ramnaraine ML; Woods WG; Krivit W
    Pediatrics; 1987 Feb; 79(2):203-5. PubMed ID: 3808793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A preliminary study of retinoblastoma-related serum tumor markers].
    Liu ZP; Zhou KY; Chen LL; Xiao ZH; Chen YZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Mar; 19(3):318-321. PubMed ID: 28302204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
    Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of homovanillic acid (HVA) and vanillylmandelic acid (VMA) in urine using gas chromatography-mass spectrometry (GC/MS).
    Allenbrand R; Garg U
    Methods Mol Biol; 2010; 603():261-9. PubMed ID: 20077077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analytical validation and clinical application of urinary vanillylmandelic acid and homovanillic acid by LC-MS/MS for diagnosis of neuroblastoma.
    Shen Y; Li H; Lu J; Luo X; Guan Q; Cheng L
    Biomed Chromatogr; 2019 Jun; 33(6):e4484. PubMed ID: 30632178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of Neuroblastoma Markers Homovanillic Acid (HVA) and Vanillylmandelic Acid (VMA) in Urine by Gas Chromatography-Mass Spectrometry (GC/MS).
    Beals M; Ramoo B; Clinton Frazee C; Garg U
    Methods Mol Biol; 2022; 2546():185-194. PubMed ID: 36127589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vanilmandelic acid and homovanillic acid levels in patients with neural crest tumor: 24-hour urine collection versus random sample.
    Gregianin LJ; McGill AC; Pinheiro CM; Brunetto AL
    Pediatr Hematol Oncol; 1997; 14(3):259-65. PubMed ID: 9185210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.
    Matser YAH; Verly IRN; van der Ham M; de Sain-van der Velden MGM; Verhoeven-Duif NM; Ash S; Cangemi G; Barco S; Popovic MB; van Kuilenburg ABP; Tytgat GAM;
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30289. PubMed ID: 37010353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: report from the Italian Cooperative Group for Neuroblastoma.
    Barco S; Gennai I; Reggiardo G; Galleni B; Barbagallo L; Maffia A; Viscardi E; De Leonardis F; Cecinati V; Sorrentino S; Garaventa A; Conte M; Cangemi G
    Clin Biochem; 2014 Jun; 47(9):848-52. PubMed ID: 24769278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of catecholamine excretion levels in diagnosis and treatment of neuroblastoma.
    Bond JV
    Arch Dis Child; 1975 Sep; 50(9):691-5. PubMed ID: 1190818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum CA125 and NSE: biomarkers of disease severity in patients with silicosis.
    Fang SC; Zhang HT; Wang CY; Zhang YM
    Clin Chim Acta; 2014 Jun; 433():123-7. PubMed ID: 24642341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urine neuron-specific enolase and its clinical implication in patients with neuroblastoma.
    Gotoh Y; Hashimoto K; Tada K
    Tohoku J Exp Med; 1986 May; 149(1):67-72. PubMed ID: 3738918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.